Log in to save to my catalogue

Halogenated boroxine increases propensity to apoptosis in leukemia (UT‐7) but not non‐tumor cells in...

Halogenated boroxine increases propensity to apoptosis in leukemia (UT‐7) but not non‐tumor cells in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d76e81d17cdb425686271347d68a23a6

Halogenated boroxine increases propensity to apoptosis in leukemia (UT‐7) but not non‐tumor cells in vitro

About this item

Full title

Halogenated boroxine increases propensity to apoptosis in leukemia (UT‐7) but not non‐tumor cells in vitro

Publisher

England: John Wiley & Sons, Inc

Journal title

FEBS open bio, 2023-01, Vol.13 (1), p.143-153

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

A hallmark of the development of solid and hematological malignancies is the dysregulation of apoptosis, which leads to an imbalance between cell proliferation, cell survival and death. Halogenated boroxine [K2(B3O3F4OH)] (HB) is a derivative of cyclic anhydride of boronic acid, with reproducible anti‐tumor and anti‐proliferative effects in differe...

Alternative Titles

Full title

Halogenated boroxine increases propensity to apoptosis in leukemia (UT‐7) but not non‐tumor cells in vitro

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d76e81d17cdb425686271347d68a23a6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d76e81d17cdb425686271347d68a23a6

Other Identifiers

ISSN

2211-5463

E-ISSN

2211-5463

DOI

10.1002/2211-5463.13522

How to access this item